BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19269547)

  • 21. Successful treatment of nicotine withdrawal with duloxetine: a case report.
    Perroud N; Relecom C; Huguelet P
    J Clin Psychopharmacol; 2008 Feb; 28(1):102-4. PubMed ID: 18204352
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hashimoto encephalopathy--a difficult differential diagnosis. A case report of reversible dementia and psychosis].
    Nunnemann C; Kratz T
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):610-5. PubMed ID: 18833507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upping the ante on antidepressants.
    Malhi GS
    Bipolar Disord; 2008 Dec; 10(8):975-8. PubMed ID: 19594513
    [No Abstract]   [Full Text] [Related]  

  • 24. Duloxetine and hyponatremia: a report of 5 cases.
    Krüger S; Lindstaedt M
    J Clin Psychopharmacol; 2007 Feb; 27(1):101-4. PubMed ID: 17224730
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment with antidepressants increases insulin-like growth factor-I in cerebrospinal fluid.
    Schilling C; Blum WF; Heuser I; Paslakis G; Wudy SA; Deuschle M
    J Clin Psychopharmacol; 2011 Jun; 31(3):390-2. PubMed ID: 21532371
    [No Abstract]   [Full Text] [Related]  

  • 26. Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression.
    Ghaemi SN
    Bipolar Disord; 2008 Dec; 10(8):957-68. PubMed ID: 19594510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is major depressive disorder a metabolic encephalopathy?
    Harvey BH
    Hum Psychopharmacol; 2008 Jul; 23(5):371-84. PubMed ID: 18435513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Management of psychological symptoms and physical symptoms of depression. Rapid re-integration of patients into employment].
    MMW Fortschr Med; 2005 May; 147 Spec No 2():86. PubMed ID: 15968880
    [No Abstract]   [Full Text] [Related]  

  • 29. Thyroid hormones affect recovery from depression during antidepressant treatment.
    Pae CU; Mandelli L; Han C; Ham BJ; Masand PS; Patkar AA; Steffens DC; De Ronchi D; Serretti A
    Psychiatry Clin Neurosci; 2009 Jun; 63(3):305-13. PubMed ID: 19566761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and treatment of a major depressive episode.
    Thase ME
    J Clin Psychiatry; 2009 Oct; 70(10):e37. PubMed ID: 19906336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Misleading report on the prevention of major depression among patients with head and neck cancer.
    Coyne JC
    Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1345; author reply 1345-6. PubMed ID: 19075135
    [No Abstract]   [Full Text] [Related]  

  • 32. The modern pharmacopoeia: a return to depressive realism?
    Goldberg JF
    Bipolar Disord; 2008 Dec; 10(8):969-72. PubMed ID: 19594511
    [No Abstract]   [Full Text] [Related]  

  • 33. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
    Tsai SJ; Hong CJ; Liou YJ; Chen TJ; Chen ML; Hou SJ; Yen FC; Yu YW
    Psychiatry Res; 2009 Sep; 169(2):113-7. PubMed ID: 19700204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of major depressive disorder in primary care.
    Dantz B
    Mich Med; 2008; 107(3):24-6. PubMed ID: 18700401
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of blonanserin in combination therapy for treatment-resistant depression.
    Kumagai R; Ichimiya Y
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):593-4. PubMed ID: 19659567
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of psychotherapy added to pharmacotherapy on cortisol responses in outpatients with major depressive disorder.
    Yang TT; Hsiao FH; Wang KC; Ng SM; Ho RT; Chan CL; Lai YM; Chen YT
    J Nerv Ment Dis; 2009 Jun; 197(6):401-6. PubMed ID: 19525739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversible paroxetine-induced symptomatic hypothyroidism.
    Takahashi M; Sawayama E; Sawayama T; Miyaoka H
    Pharmacopsychiatry; 2007 Sep; 40(5):201-2. PubMed ID: 17874352
    [No Abstract]   [Full Text] [Related]  

  • 38. Hashimoto encephalopathy presenting as schizophrenia-like disorder.
    Lin YT; Liao SC
    Cogn Behav Neurol; 2009 Sep; 22(3):197-201. PubMed ID: 19741331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treating depression after heart transplantation #273.
    Michaelsen K; Arnold RM
    J Palliat Med; 2013 Nov; 16(11):1477-8. PubMed ID: 24073686
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacologic and therapeutic strategies in treatment-resistant depression. Augmentation strategies.
    Thase ME
    CNS Spectr; 2009 Mar; 14(3 Suppl 4):7-10. PubMed ID: 19407714
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.